MAP3K5 and metabolic dysfunction-associated steatohepatitis: In particular, Rho-Associated Protein Kinase 1 (ROCK1) and Apoptosis Signal–Regulating Kinase 1 (ASK1) (MAP3K5) are found to play an important role in the progression of NAFLD to NASH through mediating lipotoxic effects [15].